Aevi Genomic Medicine Inc (NASDAQ:GNMX)

1.60
Delayed Data
As of Apr 20
 -0.09 / -5.33%
Today’s Change
0.98
Today|||52-Week Range
2.65
+33.33%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-18.4M-38.0M-41.9M-34.7M
 
 
 
 
 
Depreciation225.0K240.0K268.0K112.0K
 
 
 
 
 
Total Other Cash Flow5.5M13.5M6.8M3.4M
 
 
 
 
 
Funds From Operations-12.7M-24.2M-34.8M-31.2M
 
 
 
 
 
Funds From/For Other Operating Expenses-511.0K162.0K-2.1M2.0M
 
 
 
 
 
Net Cash Flow - Operating Activities-12.2M-24.4M-32.8M-33.2M
 
 
 
 
 
 
InvestingCapital Expenditures-364.0K-187.0K-221.0K-4.0K
 
 
 
 
 
Fixed Asset Disposal1.0K0.000.00152.0K
 
 
 
Net Cash Flow Investing-363.0K-187.0K-221.0K148.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale23.5M44.3M19.7M27.0M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing23.5M44.3M19.7M27.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash10.9M19.7M-13.2M-6.1M